Abstract -Taurine, 2-aminoethanesulfonic acid, is an abundant free amino acid present in brain cells and exerts many important biological functions such as anti-convulsant, modulation of neuronal excitability, regulation of learning and memory, anti-aggressiveness and anti-alcoholic effects. In the present study, we investigated to explore whether taurine has any protective actions against oxidative stress-induced damages in neuronal cells. ERK I/II regulates signaling pathways involved in nitric oxide (NO) and reactive oxygen species (ROS) production and plays a role in the regulation of cell growth, and apoptosis. We have found that taurine significantly inhibited AMPA induced cortical depolarization in the Grease Gap assays using rat cortical slices. Taurine also inhibited AMPA-induced neuronal cell damage in MTT assays in the differentiated SH-SY5Y cells. When the neuronal cells were treated with H 2 O 2 , levels of NO were increased; however, taurine pretreatment decreased the NO production induced by H2O2 to approximately normal levels. Interestingly, taurine treatment stimulated ERK I/II activity in the presence of AMPA or H2O2, suggesting the potential role of ERK I/II in the neuroprotection of taurine. Taken together, taurine has significant neuroprotective actions against AMPA or H2O2 induced damages in neuronal cells, possibly via activation of ERK I/II.
INTRODUCTION
Taurine (2-aminoethanesulfonic acid) is a sulfur-containing amino acid and one of the most abundant free amino acids in the central nervous system and in the mammalian brain (Saransarari and Oja, 2000; Louzada et al., 2004; Park et al., 2006) . Taurine presents with especially high concentrations in the heart, retina, neutrophils (Son et al., 2007) . Taurine plays important roles that osmoregulation, calcium transport regulation, cell membrane stabilization, immunomodulation and regulation of protein phosphorylation (Park et al., 2006; Son et al., 2007; Liao et al., 2008) . Taurine is necessary for normal development, and its deficiency leads to defects in growth, tissue differentiation, immune development, effective in preventing cardiovascular disease, ischemic heart disease (Son et al., 2007) .
Oxidative stress-induced cell damage has been widely involved in the neuronal cell death that is associated with many neurodegenerative disorders including Alzheimer's disease, Parkinson's disease, Huntington's disease, ischemic injury and amyotrophic lateral sclerosis (Ruffels et al., 2004; Zhang et al., 2007; Lin et al., 2009; Chen et al., 2009) . Oxidative stress mediated by reactive oxygen species (ROS) such as hydrogen peroxide (H2O2), superoxide radical (O 2 − ), hydroxyl radical (OH) and peroxynitrate (ONOO − ) can be generated by cell lysis, excitatory amino acids including AMPA (α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid hydrobromide), oxidative burst, DNA damage, oxidative of proteins, peroxidation of lipids and cell death including apoptosis and necrosis (Chandra et al., 2000; Ruffels et al., 2004; Zhang et al., 2007; Zhuang et al., 2007; Lin et al., 2009; Chen et al., 2009) . Though, the molecular mechanisms involved in oxidative stress-induced apoptotic neuoronal cell death are complex and remains to be characterized (Canas et al., 2007) , therapeutic strategies of preventing ROS production can be useful for the treatment of many neurodegenerative disease.
It has been suggested that ERK I/II and PKB activation promote cell survival by activating anti-apoptotic signaling pathways, whereas activation of JNK and p38 MAPK is associated with neuronal cell death (Ruffels et al., 2004) . And ERK I/II activation in neurons has been linked to pro-survival events (Vauzour et al., 2007) . The modulation of signaling through the serine/threonine kinase, Akt/PKB, one of the main downstream effectors of phosphatidylinositol 3-kinase (PI3K)/PKB pathway is involved in neuronal survival (Spencer et al., 2003; Ruffels et al., 2004) . Generally, an activation of JNK is considered pro-apoptotic, whereas activation of ERK and Akt are viewed as being pro-survival in neurons (Spencer et al., 2003) . Protein kinase B (PKB/Akt) participates in several cellular functions including cell growth, metabolism, apoptosis and translational control (Morales et al., 2006) . In the present study, we investigated to explore whether taurine has any protective actions against oxidative stressinduced damages by AMPA and H2O2 in SH-SY5Y meuroblastoma cells. Potential roles of ERK I/II in taurine's neuroprotective action have been proposed.
MATERIALS AND METHODS

Materials
Taurine (2-aminoethanesulfonic acid), All-trans-retinoic acid (RA) and 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT), Griess reagent was purchased from Sigma. α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid hydrobromide ((RS)-AMPA hydrobromide) was purchased from TOCRIS. The reagents used for polyacrylamide gel electrophoresis were from Bio-Rad. Nitrocellulose filters (0.45 μm) were purchased from Whatman. Antibodies to p44/p42 MAP kinase (ERK1/2) and phospho-p44/p42 MAP kinase were purchased form Cell signaling. An ECL kit was purchased from Amersham. The human neuroblastoma cell line SH-SY5Y were obtained from the Korean Cell Line Bank (Seoul, Korea). And all other chemicals were purchased form Sigma Chemical Company.
Cell culture
SH-SY5Y cells were cultured in MEM alpha medium (MEM) supplemented with 100 U/ml of penicillin, 100 μg/ml of streptomycin and 10% Fetal Bovine Serum (FBS) at 37 o C in 5% CO2 and 95% Air. Cells were plated at a density of 1×10 5 cells per well in 6-well. SH-SY5Y cells were induced to differentiate into neuronal cells by the Retinoic acid (RA ; 10 uM). SH-SY5Y cells are often induced to differentiated by All-trans-retinoic acid (RA) to obtain more neuron-like properties, including neurite outgrowth and morphological changes (Cheung et al., 2009) . Fresh retinoic acid were added every 48 h and treated for 5-7 days. Cells were washed with phosphate-buffered saline (PBS) three times and incubated with serum-free media for 18 h, followed by taurine treatment (10 mM). After indicated times, AMPA (40 uM) or H2O2 (0.2 mM) added for subsequent experiments.
Preparation of brain slices
To prepare of cortical slices is according to the mothod of Harrison and Simmonds (1985; Kim and Han, 2005) . "Wedges" of rat cerebral cortex were prepared from the brains of male Wistar rats (200 g). The animals were decapitated and the brain rapidly removed into chilled oxygenated (95% O2/5% CO2) artificial cerebrospinal fluid (ACSF) containing NaCl (122 mM), NaHCO3 (25 mM), KCl (3.1 mM), KH 2 PO 4 (0.4 mM), CaCl 2 (1.3 mM), MgSO 4 (1.4 mM), and D-glucose (10 mM) at a pH of 7.4. Coronal slices (500 μm) were made taken with a Tissue Slicer (Stoelting, Wood Dale, IL). The slices were then placed in oxygenated ACSF at room temperature and hemi-sected with a razor and set with an edge of tissue such that the dorsal cortical surface was approximately 1.5 mm wide and the vental surface formed a point. The wedges were further incubated in ACSF for 2 h at room temperature (Kim and Han, 2005) .
Electrophysiological experiments on brain slices (grease-gap recording)
The grease-gap recording assays were carried out as described by Black et al. (2000) . Cortical wedges were placed in a two-compartment bath (Experimetria, Hungary); a greased (high vaccum silicon grease) barrier was placed to form a high-resistance seal between the two compartments. Oxygenated ACSF was perfused through the two compartments separately at 2 ml/min for at least 1 h. Taurine was perfused 10 min before the application of AMPA (40 uM) for 2 min.
MTT assay
SH-SY5Y cells' viability was measured by MTT assay. The cells were plated in 96-well plates at a density of 1× 10 5 cells/well. Following taurine treatment for 24 hr, the cells were treated with MTT (0.5 mg/ml) and allowed to incubate for 3 hr. The culture medium was removed, the cells were subjected to lysis in the presence of 100 μl of DMSO and 10 μl of Sorenson glycine buffer, and absorbance was measured with a spectrophotometer at 540 nm (Park et al., 2001) .
Fig. 1.
Effects of taurine on AMPA-induced depolarization in brain slices. Depolarization using the grease gap assay was performed as described in the Materials and Methods. Taurine (10 mM) were superfused for 10 min and AMPA (40 μM) was applied for 2 min while taurine was being superfused. The DC potential between the two compartments was monitored via Ag/AgCl electrodes. The signal was amplified and analyzed with the aid of McLab software. All data were expressed as mean ± S.E.M. of three experiments and each included triplicate sets. **p＜0.01, difference with control group. Data are presented as the percentage of depolarization.
Nitric oxide measurement
The nitrite oxide levels in cultured medium was measured as an indicator of NO production based on the Griess reaction. 75 μl of cell culture medium was mixed with equal volume of Griess reagent and incubated at room temperature for 15 min. And then, the absorbance at 540 nm was measured in a microplate reader. Fresh culture medium was used as the blank in all experiments. The amount of nitrite in the samles was measured with the sodium nitrite serial dilution standard curve and nitrite production was measured .
Western blot analysis
The treated cells (1×10 5 or 10 6 cells/ml of 6 well plates)
were collected and washed with Phosphate Buffered Saline (PBS) twice. After aspiration, cells were lysed in a lysis buffer containg 10 mM Tris-HCl, pH 7.4, 50 mM Sodium Chloride (NaCl), 5 mM Ethylenediaminetetraacetic Acid (EDTA), 30 mM Sodium Fluoride (NaF), 0.1 mM Sodium Orthovanadate (Na 3 VO 4 ), 1% TX-100, 10% Nonidet-P40 (NP-40), 1 μg/ml Leupeptin, 1 μg/ml Aprotinin, 1 mM pheyl methyl sulfonyl fluoride (PMSF). The lysates were incubated on ice for overnight and centrifuged at 13,000 rpm for 10 min. Supernatants were collected and followed by protein concentration determination by Bradford Assay. Protein samples were separated by electrophoresed on 10% SDS-polyacrylamide gel, and transferred to a nitrocellulose membrane. The transfer membrane was incubated in blocking buffer (5% non-fat skim milk in TBST buffer) for 1 h at room temperature. The blots were probed with primary antibody that ERK1/2, phospho-ERK1/2, for overnight at 4 o C. Membranes were washed three times for 10 min using TBST buffer. After that there were incubated with secondary antibody (Anti-rabbit, 1:1000) for 3 h at room temperature and wash three times with TBST buffer. Membranes were detected of immobilized specific antigens was carried out by enhanced chemiluminescence (ECL). There band were detected by ChemiDcXRS sytem (Bio-rad).
Statistics
All values are expressed as means ± S.E.M. Comparison between groups was performed by t-test. The statistical difference was set at p＜0.05, p＜0.01 and p ＜0.001.
RESULTS
Effect of taurine on the AMPA-induced depolarization in brain slices
We tested to determine if taurine has any effect on the AMPA-induced excitotoxicity in brain slices through the grease-gap recording assay. Pretreatment with taurine (10 mM) resulted in the inhibition of AMPA (40 uM)-induced depolarization by approximately 50% compared to controls, supporting taurine's neuroprotective activity (Fig. 1) .
Effect of taurine on AMPA-induced cells damages in SH-SY5Y neuroblastoma cells
We also tested to determine if taurine has any protective effects against AMPA-induced damages in SH-SY5Y neuroblastoma cells. SH-SY5Y cells were exposed to AMPA (40 uM) for 24 h in the absence and presence of taurine (10 mM) and cell viability was assessed by MTT assays. As shown in Fig. 2 , AMPA decreased cell viability on SH-SY5Y neuroblastoma cells. AMPA treatment in the presence of taurine increased cell viability as compared to AMPA alone. Taurine itself had little effects on the cell viability.
Fig. 2.
Effects of taurine on AMPA-induced cell death in SH-SY5Y neuroblastoma cells. Taurine (10 mM) was pretreated and then 40 μM AMPA treated 24 h. All data were expressed as mean ± S.E.M. of three experiments and each included triplicate sets. ***p＜0.001 difference with control group. Fig. 3 . Effects of taurine on AMPA-induced NO levels in SH-SY5Y neuroblastoma cells. Taurine (10 mM) was pretreated for the indicated times and followed by treatment with H2O2. Nitric oxide was measured with Griess reagent. All data were expressed as mean ± S.E.M. of three experiments and each included triplicate sets. *p＜0.05, **p＜0.01, difference with control (non-treated) group. 
Effect of taurine on the NO production in response to H 2 O 2 in SH-SY5Y neuroblastoma cells
Since NO is an important mediator for oxidative stressinduced neuronal damage, we tested to determine if taurine has any inhibitory effect on the H2O2-induced NO production. H2O2 treatment (0.2 mM) to the SH-SY5Y neuroblastoma cells increased NO production by 20% as compared to control. However, taurine treatment in the presence of H2O2 significantly diminished the NO production in 30 min to 60 min to almost control levels (Fig. 3) .
Effect of taurine in AMPA-induced ERK I/II phosphorylation in SH-SY5Y neuroblastoma cells
In the central nervous system, ERK I/II is a critical enzyme for neuronal differentiation, plasticity and survival. Considering that ERK I/II mediates neuroprotective activity of extracellular factors (Lin et al., 2009) , we explored whether AMPA induces any changes in the activities of ERK I/II in SH-SY5Y cells and tested if taurine could affect the AMPA's avtion on ERK I/II. The cells were exposed to AMPA (40 uM) for the indicated times. AMPA treatment slightly increased phosphorylation of ERK I/II at 10 min, however, phosphorylation levels decreased in 30 min to 120 min (Fig. 4) .
To test if taurine has stimulatory effect under AMPA-induced cell damage, the cells were pre-treated with 10 mM taurine for indicated times and followed by the treatment with AMPA for 30 min. Taurine transiently stimulated ERK I/II phosphorylation at 10 min by approximately 2-fold over basal; however, the activated ERK I/II returned to basal levels (Fig. 5) . were analysed for ERK I/II phosphorylation by Western blot analysisas described in Materials and Methods (A). The ratio of phosporylated ERK to ERK is determined by comparing the relative intensities of protein bands (B). All data were expressed as mean ± S.E.M. of three experiments and each included triplicate sets. *p＜0.05, **p＜0.001, ***p＜0.0001, difference with control group. Fig. 7 . Effects of taurine on H2O2-induced activation of ERK I/II in SH-SY5Y neuroblastoma cells. Differentiated SH-SY5Y cells were pretreated with the taurine (10 mM) for the indicated times and then stimulated with H2O2 for 30 min. Cell lysates (30 μg protein) were analysed for ERK 1/2 phosphorylation by Western blot analysis as described in Materials and Methods (A). The ratio of phosporylated ERK to ERK is determined by comparing the relative intensities of protein bands (B). All data were expressed as mean ± S.E.M. of three experiments and each included triplicate sets. *p＜0.05, **p＜0.001, ***p＜0.0001, difference with control group.
Effect of taurine on ERK I/II phosphorylation under H 2 O 2 -induced oxidative stress in SH-SY5Y neuroblastoma cells
When cells were incubated with H 2 O 2 for up to 120 min, phosphorylation of ERK I/II was slightly stimulated at 10 min; however, it was significantly decreased by about 40%, 80% and 98% compared to the control at 30 min, 60 min and 120 min, respectively (Fig. 6) . On the other hand, when cells were pre-treated with taurine for the indicated times in the presence of H 2 O 2 , the phosphorylation of ERK I/II was increased by approximately 2-fold over the control in response to taurine (Fig. 7) .
DISCUSSION
Oxidative stress induced by excitatory amino acids such as AMPA and ROS plays a critical role in neuronal cell death, causing various neurodegenerative diseases including Parkinson's disease, Alzheimer's disease etc. Development of neuroprotective agents is essential for the prevention of neurodegenerative diseases. We explored to determine if taurine exerts neuroprotective actions against oxidative stress-induced neuronal damages and sought to investigate the potential role of ERK I/II in the taurine's neuroprotective actions. It has been identified that taurine has significant neuroprotective actions and potential involvement of ERK I/II in the same process has been presented.
Neuronal cell death is a major cause of neurodegenerative disease, thus neuroprotection is critical process in preventing brain diseases. Excitatory amino acids including NMDA, AMPA and kainic acid are present in various regions of the CNS. AMPA induces neuronal degeneration, displaying cytoplasmic and nuclear condensation, neuron shrinkage (Gartwaite and Gartwait, 1991; , as well as some morphological characteristics of neurotoxicity observed in stroke head trauma and seizures (Kalimo et al., 1980; Soderfeldt et al., 1981; Griffins et al., 1984; Simon et al., 1984; Van Reempts, 1984; Sato et al., 1990; Vartanian et al., 1996) . AMPA causes delayed cytotoxicity which is associated with various forms of apoptosis including DNA laddering into internucleosomal sized fragments and morphological damage .
Taurine exerts various biological actions in the peripheral cells including osmo-regulation, regulation of glucose metabolism, insulin-like activity, and anti-oxidant actions. In the CNS, taurine is one of the most abundant free amino acids, suggesting its importance for the critical brain activites. Under damaging conditions such as osmotic imbalance, fever and is ischemia-hypoxia, taurine is released in high amounts from brain cells Oja, 2000, 2007; Frosini, 2007) . Interestingly, the release of excitatory amino acids including AMPA under ischemic condition occurs simultaneously with the release of taurine, suggesting taurine's potential neuroprotective actions against excitatory amino acid-induced neuronal damages (Saransaari and Oja, 1999 , 2000b , 2007 ). Taurine's neuroprotective effects has also been further supported by the fact that taurine-containing neurons are resistant to cerebral ischemia induced by four-vessel occlusion in rats (Wu et al., 1994) . However, mechanisms of taurine's neuroprotection remains to be fully characterized.
In the present study, it has been clearly demonstrated that taurine has the ability to protect neuronal cells by grease-gap test as well as MTT assay. Nitric Oxide (NO) has been suggested to play a role as an intracellular mediator of neuronal cell death upon NMDA receptor activation as well as a cell-cell interactive type of neuronal cell death (Lipton et al., 1993 ). Taurine's inhibitory action against H 2 O 2 -induced NO production in the SH-SY5Y cells suggest its potential neuroprotective effect against oxidative stress.
In terms of potential mechanisms of taurine's neuroprotection, we have found that taurine transiently further stimulate ERK I/II phosphorylation in the presence of AMPA and has the ability to protect the inhibition of its phosphorylation by AMPA. Phosphorylation is an important posttranslational modification for the activation of ERK I/II and it is regarded as an index of the enzyme's activity. These results suggest that activation of ERK I/II may play a role in the neuroprotection in response to taurine.
Taurine's action on the ERK I/II phosphorylation in the presence of H2O2 is more prominent and its actions are persisting. Recently, it has been suggested that ERK I/II plays an essential role in the neuroprotective processes (Wu et al., 2004; Shen et al., 2009; Jiang et al., 2009) . Our study present evidence for the first time that ERK I/II activation by taurine may be an important step for the neuroprotection exerted by taurine.
In summary, it has been clearly demonstrated that taurine has significant neuroprotective actions against oxidative stress-induced cell damages in the SH-SY5Y neuroblastoma cells. A potential role of ERK I/II activation has been proposed as a mechanism of neuroprotection by taurine. Taurine's neuroprotective effect could be beneficial in the prevention and treatment of neurodegenerative diseases.
